Patients with Metastatic Prostate Cancer

TON Interview with the Innovators: Volume 1
Pam Skurkay discusses the comparison rate of skeletal related events in bisphosphonates versus Xgeva.

Related Items


Subscribe Today!

To sign up for our newsletter or print publications, please enter your contact information below.

I'd like to receive: